Avacopan for ANCA-Associated Vasculitis in Ireland: A Report on All Patients Who Received Avacopan in the Irish Health Care System

被引：0
|
作者：
Nic an Riogh, Eithne Muireann [1 ]
Cummiskey, Andy Gerard [2 ]
Stoneman, Sinead [3 ]
Clarkson, Michael [3 ]
Moran, Sarah Margaret [3 ]
Magee, Ciara N. [4 ]
McAnallen, Susan Marie [5 ]
Little, Mark Alan [1 ]
机构：
[1] Trinity Coll Dublin, Trinity Translat Med Inst, Dublin, Ireland
[2] Mater Misericordiae Univ Hosp, Dublin, Ireland
[3] Cork Univ Hosp, Cork, Cork, Ireland
[4] Beaumont Hosp, Dublin, Ireland
[5] St James Hosp, Dublin, Ireland
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024z11kxv8c
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO738
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Avacopan for the Treatment of ANCA-associated Vasculitis. Real World Experience in Spain
    Espigol-Frigole, Georgina
    Cid, Maria C.
    Bordignon Draibe, Juliana
    Carmen Prados, Maria
    Guillen, Elena
    Huerta, Ana
    Villacorta, Javier
    Vega, Cristina
    Martins, Judith
    Gracia, Borja
    Morales, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1369 - 1370
  • [42] Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
    van Leeuwen, Jolijn R.
    Quartuccio, Luca
    Draibe, Juliana Bordignon
    Gunnarson, Iva
    Sprangers, Ben
    Teng, Y. K. Onno
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19
  • [43] Avacopan for the Treatment of ANCA-Associated Vasculitis (vol 384, pg 599, 2021)
    Jayne, David R. W.
    Merkel, Peter A.
    Schall, Thomas J.
    Bekker, Pirow
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (04): : 388 - 388
  • [44] Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan
    Luis Alvarez
    Neeraja Kambham
    Robert Su
    Journal of Nephrology, 2023, 36 : 2365 - 2370
  • [45] Report on Twelve Patients with Diffuse Alveolar Hemorrhage in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
    Specks, Ulrich
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1364 - 1366
  • [46] Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
    van Leeuwen, Jolijn R.
    Teng, Yoe Kie Onno
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 499 - 500
  • [47] Avacopan in ANCA-associated Vasculitis Received Intensified Induction Therapy with Cyclophosphamide Plus Rituximab - Retrospective Case Serial of 12 Patients
    Assmann, Gunter
    Rittich, Christoph
    Neumann, Frank
    Kellner, Udo
    Turkiewicz, Ryszard
    Radermacher, Joerg
    Lamprecht, Peter
    Tampe, Bjoern
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1361 - 1362
  • [48] Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1366 - 1367
  • [49] Avacopan for the treatment of ANCA-associated vasculitis: an update (vol 19, pg 461, 2023)
    Osman, M.
    Tervaert, J. W. C.
    Pagnoux, C.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 321 - 321
  • [50] Glucocorticoid Use and Related Adverse Events in ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis
    De Gomma, Emil
    Merkel, Peter
    George, Michael
    Rhee, Rennie
    Kronbichler, Andreas
    Jayne, David
    Yue, Huibin
    Bekker, Pirow
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2144 - 2146
12345